RE:GUD things are Afoot!GoldenInvestor wrote: Roughly, JRG in two days, adds almost $400k, give or take..
The newly minted CEO is in for almost an additional $40,000.
Agian, not the kind of action any Captial Allocator/Pharma investors would make unless they see grand opportuntities before them.
Do you think they have anything to base these investment decision upon?
Have they had any significant experience to go by?
Even as the broader market is elevated, prudent Investment analysis takes hold.
The probabilities of success must greatly outweigh the risks, if any.
GI
Absolutely Golden.
Huge confidence from the inside.
Outside will eventually get it - not something management worries about because they have no control. They're not looking for a quick win anyway - they're in it for the longterm.
Goodman - won't sell one share until he sells them all - same motto 2nd time around. There is no reason to believe otherwise.
We've heard whining in the past about Goodman taking this private - didn't do it with the first as his commitment to shareholders was high then ... continues to be high for present shareholders.
All about growth now !!!
Did you see the difference in growth in Canada vs. LATAM (in new presentation)? Absolutely why LATAM was the right target for GUD.
Did you see the number of employees we have in Argentina? Half - roughly 350.
Taking a look at average wages in Argentina, we'd be paying $1M CAD annually for those 350 but I'm sure we're a little higher than that.
Regardless ... what I'm getting at is ... this company has options and if they really wanted to ... future expansion could happen in similar or even lower cost environments. At some point, depressed currencies turn and that has a negative effect on wages but a more powerful effect on sales dollars.
I really like the partnering they can do with smaller-to-mid-size drug developers. While those companies are focusing on selling/partnering in USA and Europe - Knight can move them into all these smaller regions "YEARS" before they could even dream of getting there on your own - or - reducing the complexities of trying to do it with multiple partners. One-stop-shop has huge benefits (big win-win) as it can get these small/mid-size companies to more reoccurring revenue faster. What they need to grow their businesses.
Can't wait to see the next moves over 2022-2023. Developments hould be more exciting as a function of time now. IMO.